It was recently reported that some molecules or cells played an important role in HCC progression and might be the potential target for HCC therapy, such as Polo-like kinase 1, the insulin-like growth factor and cytokine-induced kill cells[50–52]. The gene discussed is PLK1; the disease is hepatocellular carcinoma.